Sclerostin was originally discovered because of inactivating mutations in the coding and enhancer regions of the SOST gene that cause the rare high bone mass disorders sclerosteosis and van Buchem disease (78). This evidence concerns the gene SOST and hyperostosis corticalis generalisata.